HKEX:255 stock news
This page provides real-time market news, earnings updates, and company announcements related to Lung Kee Group Holdings Limited (HKEX:255).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 19:55 HKT
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
Finviz2026-02-24 12:03:59
Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
Finviz2026-02-24 13:03:09
Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
Finviz2026-02-24 13:03:09
Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston
Finviz2026-02-24 13:06:43
SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus
Finviz2026-02-24 17:39:42
Aktis Oncology to Present at Upcoming March Investor Conferences
Finviz2026-02-24 21:09:41
Prime Medicine to Participate in Upcoming Investor Conferences
Finviz2026-02-25 13:03:47
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference
Finviz2026-02-25 13:34:29
Is Johnson & Johnson Able to Maintain Its Strong Double-Digit Growth in Oncology?
101 finance2026-02-25 14:57:58
TMDX Shares Climb After Q4 Earnings and Revenue Surpass Expectations
101 finance2026-02-25 17:57:51
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase
Finviz2026-02-25 18:04:04
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-25 21:09:44
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
Finviz2026-02-26 12:03:47
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 12:33:48
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors
Finviz2026-02-26 13:03:41
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 13:03:43
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-02-26 14:06:40
UTHR Beats Q4 Earnings Expectations, Stock Jumps 13% Following Robust Outlook
101 finance2026-02-26 15:13:13
Iovance Biotherapeutics (IOVA) Reports 61% Annual Revenue Growth Driven by Amtagvi Success
Finviz2026-02-26 19:30:40
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
Finviz2026-02-26 21:03:46
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
Finviz2026-02-26 21:03:46
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 21:21:41
SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus
Finviz2026-02-24 17:39:42
Aktis Oncology to Present at Upcoming March Investor Conferences
Finviz2026-02-24 21:09:41
Prime Medicine to Participate in Upcoming Investor Conferences
Finviz2026-02-25 13:03:47
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference
Finviz2026-02-25 13:34:29
Is Johnson & Johnson Able to Maintain Its Strong Double-Digit Growth in Oncology?
101 finance2026-02-25 14:57:58
TMDX Shares Climb After Q4 Earnings and Revenue Surpass Expectations
101 finance2026-02-25 17:57:51
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase
Finviz2026-02-25 18:04:04
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-25 21:09:44
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
Finviz2026-02-26 12:03:47
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 12:33:48
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors
Finviz2026-02-26 13:03:41
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 13:03:43
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-02-26 14:06:40
UTHR Beats Q4 Earnings Expectations, Stock Jumps 13% Following Robust Outlook
101 finance2026-02-26 15:13:13
Iovance Biotherapeutics (IOVA) Reports 61% Annual Revenue Growth Driven by Amtagvi Success
Finviz2026-02-26 19:30:40
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
Finviz2026-02-26 21:03:46
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
Finviz2026-02-26 21:03:46
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 21:21:41
HKEX:255 stock price change
On the last trading day, HKEX:255 stock closed at 1.50 HKD, with a price change of 0.67% for the day.
Trade stock perpsHKEX:255 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more